Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.58 USD
Change Today 0.00 / 0.00%
Volume 0.0
MABA On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 06/30/15 All times are local (Market data is delayed by at least 15 minutes).

amer biogenetic sciences-a (MABA) Snapshot

Open
$0.58
Previous Close
$0.58
Day High
$0.58
Day Low
$0.58
52 Week High
06/16/15 - $1.30
52 Week Low
09/24/14 - $0.15
Market Cap
631.5K
Average Volume 10 Days
832.1
EPS TTM
$-0.04
Shares Outstanding
1.1M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AMER BIOGENETIC SCIENCES-A (MABA)

Related News

No related news articles were found.

amer biogenetic sciences-a (MABA) Related Businessweek News

No Related Businessweek News Found

amer biogenetic sciences-a (MABA) Details

American Biogenetic Sciences, Inc. does not have significant operations. It intends to seek an acquisition or merger with an operating company. Previously, the company was engaged in the research, development, and marketing of cardiovascular and neurobiology products for commercial development; and distribution of vaccines. American Biogenetic Sciences, Inc. was founded in 1983 and is based in Greenwich, Connecticut.

amer biogenetic sciences-a (MABA) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: --
Compensation as of Fiscal Year 2014.

amer biogenetic sciences-a (MABA) Key Developments

American Biogenetic Sciences, Inc. Announces Management Changes

On May 27, 2015, the board of directors of American Biogenetic Sciences, Inc. appointed Mr. Troy Grogan to the company's board of directors and, at the same time, appointed Mr. Grogan to serve as the company's chief financial officer. Mr. Grogan has been a principal shareholder of the company since August 2010. Prior to Mr. Grogan's appointment, Mr. Richard Rubin had been the company's sole executive officer and director. Mr. Rubin will continue to serve as the company's chief executive officer and as chairman of the board of directors. Troy Grogan, was the founder, president and chief executive officer of MedScience Research Group, Inc. in May 2013. Prior to MedScience, Mr. Grogan was an entrepreneur with business experience in preventative health care in Australia and North America, having organized Greatest Asset Pty Ltd.

American Biogenetic Sciences, Inc. announced delayed annual 10-K filing

On 03/31/2015, American Biogenetic Sciences, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

American Biogenetic Sciences, Inc. announced delayed 10-Q filing

On 08/14/2014, American Biogenetic Sciences, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MABA:US $0.58 USD 0.00

MABA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MABA.
View Industry Companies
 

Industry Analysis

MABA

Industry Average

Valuation MABA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMER BIOGENETIC SCIENCES-A, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.